Pnwtri ...I wish President Trump all the best in
Post# of 148234
IMO all his plans should slow down HIV but it will not stop , and it will not cure exciting patients .
and it will not affect Leronlimab in any negative way .,
We have right now about 37 mill HIV positive patients globally , those patients will require treatment until vaccine and cure is not here ..
And this will take many years ..I believe ..
Another thing is there are many patients with drug resistant HIV , in USA many , but globally much , much more .,
Right now more patients are infected in some areas from the beginning with drug resistant virus then not ..
All those patients , globally in mill's , should be now on Leronlimab , since for now it is the best .
Another thing , knowing now more about HIV , HAART , and fibrosis of the liver ,
possibly , if our NASH clinical study will be positive , all patients HIV positive , on HAART or not , may need Leronlimab to protect their livers .
There is no problem for Leronlimab , let’s just be approve for combo , and let’s start pivotal mono and PrEP ,
I have a feeling that our PrEP globally will be giant ,
And in couple of years we should be once a month, and hopefully still without serious side effects ,
At this time there is no real competition to Leronlimab , and nothing is coming soon !!!
IMO as always .
. ,